NATR

Nature's Sunshine Products, Inc.$13.09-0.39 (-2.86%)

Prev Close$13.45·MCap$277.3M·P/E11.90·Vol92.3K·Yield0.06%

▲

Buys (12M)

$2.12M

▼

Sells (12M)

$290.0K

◆

Net Activity

Net Buyer

$1.83M

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Nature's Sunshine Products, Inc. (NATR) has been dominated by buying, with 2 insider purchases totaling $2.12M and 4 insider sales totaling $290.0K. The most recent insider transaction was by PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. (10 percent owner), who purchased $293.8K worth of shares on Aug 19, 2026. Nature's Sunshine Products, Inc. operates in the Consumer Defensive sector, within the Packaged Foods industry, with a market cap of $277.3M.

NATR Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Aug 19, 2026	PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.	10 percent owner	Buy	20,000	$14.69	$293.8K	1,944,486
Aug 10, 2026	PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.	10 percent owner	Buy	111,389	$16.37	$1.82M0.6% OS	1,924,486
Nov 14, 2025	Brower Nathan G	EVP, General Counsel	Sell	3,800	$20.81	$79.1K	0
Nov 12, 2025	Norman Daniel C	EVP & President, Asia	Sell	8,884	$20.46	$181.8K	0
Nov 4, 2025	Brower Nathan G	EVP, General Counsel	Sell	985	$13.75	$13.5K	0
Nov 4, 2025	Yates Bryant J	EVP & President, Europe	Sell	1,134	$13.75	$15.6K	0
Mar 10, 2025	Comstock Tracee	VP, Human Resources	Sell	834	$14.50	$12.1K	0
Mar 10, 2025	Herbert Kevin R.	EVP & President, North America	Sell	980	$14.50	$14.2K	0
Oct 17, 2024	Shanghai Fosun Pharmaceutical (Group) Co., Ltd.	10% Owner	Sell	2,300	$13.02	$29.9K	64,167
Oct 15, 2024	Shanghai Fosun Pharmaceutical (Group) Co., Ltd.	10% Owner	Sell	10,895	$13.33	$145.2K	75,963
Sep 19, 2022	WYNNEFIELD PARTNERS SMALL CAP VALUE LP	10% Owner	Buy	5,000	$8.93	$44.7K	1,699,139
Sep 12, 2022	WYNNEFIELD PARTNERS SMALL CAP VALUE LP	10% Owner	Buy	4,418	$9.30	$41.1K	1,695,708
Sep 6, 2022	WYNNEFIELD PARTNERS SMALL CAP VALUE LP	10% Owner	Buy	8,599	$9.51	$81.8K	1,692,622
Aug 31, 2022	WYNNEFIELD PARTNERS SMALL CAP VALUE LP	10% Owner	Buy	10,867	$9.63	$104.7K	1,686,721
Aug 29, 2022	WYNNEFIELD PARTNERS SMALL CAP VALUE LP	10% Owner	Buy	38,290	$9.71	$371.7K	1,679,264
Aug 25, 2022	WYNNEFIELD PARTNERS SMALL CAP VALUE LP	10% Owner	Buy	7,169	$9.99	$71.6K	1,652,989

NATR Insider Buying Activity

The following table shows recent insider purchases of Nature's Sunshine Products, Inc. (NATR) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Aug 19, 2026	PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.	10 percent owner	Buy	20,000	$14.69	$293.8K	1,944,486
Aug 10, 2026	PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.	10 percent owner	Buy	111,389	$16.37	$1.82M0.6% OS	1,924,486
Sep 19, 2022	WYNNEFIELD PARTNERS SMALL CAP VALUE LP	10% Owner	Buy	5,000	$8.93	$44.7K	1,699,139
Sep 12, 2022	WYNNEFIELD PARTNERS SMALL CAP VALUE LP	10% Owner	Buy	4,418	$9.30	$41.1K	1,695,708
Sep 6, 2022	WYNNEFIELD PARTNERS SMALL CAP VALUE LP	10% Owner	Buy	8,599	$9.51	$81.8K	1,692,622
Aug 31, 2022	WYNNEFIELD PARTNERS SMALL CAP VALUE LP	10% Owner	Buy	10,867	$9.63	$104.7K	1,686,721
Aug 29, 2022	WYNNEFIELD PARTNERS SMALL CAP VALUE LP	10% Owner	Buy	38,290	$9.71	$371.7K	1,679,264
Aug 25, 2022	WYNNEFIELD PARTNERS SMALL CAP VALUE LP	10% Owner	Buy	7,169	$9.99	$71.6K	1,652,989

NATR Insider Selling Activity

The following table shows recent insider sales of Nature's Sunshine Products, Inc. (NATR) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Nov 14, 2025	Brower Nathan G	EVP, General Counsel	Sell	3,800	$20.81	$79.1K	0
Nov 12, 2025	Norman Daniel C	EVP & President, Asia	Sell	8,884	$20.46	$181.8K	0
Nov 4, 2025	Brower Nathan G	EVP, General Counsel	Sell	985	$13.75	$13.5K	0
Nov 4, 2025	Yates Bryant J	EVP & President, Europe	Sell	1,134	$13.75	$15.6K	0
Mar 10, 2025	Comstock Tracee	VP, Human Resources	Sell	834	$14.50	$12.1K	0
Mar 10, 2025	Herbert Kevin R.	EVP & President, North America	Sell	980	$14.50	$14.2K	0
Oct 17, 2024	Shanghai Fosun Pharmaceutical (Group) Co., Ltd.	10% Owner	Sell	2,300	$13.02	$29.9K	64,167
Oct 15, 2024	Shanghai Fosun Pharmaceutical (Group) Co., Ltd.	10% Owner	Sell	10,895	$13.33	$145.2K	75,963